Back to Journals » Cancer Management and Research » The Cancer Treatment Revolution and the Threat to Equitable Global Medicines Access
Cancer Management and Research
ISSN: 1179-1322
- View all (4632)
- Volume 16, 2024 (38)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Journal Articles:
- The Cancer Treatment Revolution and the Threat to Equitable Global Medicines Access (2)
- Establishing New Standards in Neuroendocrine Tumors: Raising the Bar to Set New Benchmarks (1)
The Cancer Treatment Revolution and the Threat to Equitable Global Medicines Access
There has been an unparalleled advancement in cancer therapeutics development, including personalized medicine, that has led to a global decline in cancer mortality across different cancer types, mostly in high income countries. Notably, more than 300 new anti-cancer drugs have been approved in the last decade alone. Furthermore, spending on cancer medicines exceeded $180 billion globally in 2021 with the vast majority focused in the major developed markets. As thrilling as this innovative therapeutic landscape is, it remains a challenge to ensure that all patients who need these cancer therapeutics can access them at the point of care. This Collection includes papers that address inequities in access to cancer therapeutics globally and approaches for closing the equity gap.
Potential of Indonesian Herbal as an Anti-Cancer Therapy: A Systemic Review of in vitro Studies
Permatasanti A, Hidayat W
Cancer Management and Research 2023, 15:837-850
Published Date: 17 August 2023
Challenges and Strategies for Improving Access to Cancer Drugs in Malaysia: Summary of Opinions Expressed at the 2nd MACR International Scientific Conference 2022
Tan SC, Poh WT, Yong ACH, Chua EW, Ooi DJ, Mahmud R, Thiagarajan M, Stanslas J
Cancer Management and Research 2023, 15:851-862
Published Date: 21 August 2023